Literature DB >> 10423766

201Tl SPET in the differential diagnosis of brain tumours.

S Taki1, K Kakuda, K Kakuma, K Kobayashi, M Ohashi, S Ito, M Yokoyama, Y Annen, N Tonami.   

Abstract

The aims of this study were to assess the utility of 201Tl single photon emission tomography (SPET) in the differential diagnosis of brain tumours and to elucidate the relationship between 201Tl tumour uptake and degree of contrast-enhancement on magnetic resonance imaging (MRI). Early (15 min) and delayed (3 h) 201Tl SPET imaging and T1-weighted MRI were performed before and after Gd-DTPA enhancement in 101 (41 malignant and 60 benign) untreated brain tumours. The 201Tl uptake ratio (tumour-to-normal brain count ratio) for both the early and delayed SPET studies and the retention index (the ratio of delayed to early 201Tl uptake) were calculated. Malignant tumours were separated from benign tumours with 87% accuracy based on the assumption that tumours with a 201Tl retention index < 0.7 or no abnormal uptake are benign. Meningiomas and pituitary adenomas were differentiated from other benign tumours by their characteristic pattern on SPET. The degree of contrast-enhancement of the tumour on MRI was concordant with the early 201Tl uptake ratio for most histological types. However, schwannomas and cavernous haemangiomas showed a low 201Tl uptake ratio in spite of a high degree of contrast-enhancement on MRI. In conclusion, 201Tl SPET provides additional information that helps in the differential diagnosis of brain tumours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423766     DOI: 10.1097/00006231-199907000-00007

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Neuroradiological assessment of newly diagnosed glioblastoma.

Authors:  Srini Mukundan; Chad Holder; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

2.  Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma.

Authors:  Sho Osawa; Masahiko Tosaka; Keishi Horiguchi; Azusa Tokue; Tetsuya Higuchi; Yoshito Tsushima; Yuhei Yoshimoto
Journal:  Int J Clin Oncol       Date:  2022-05-13       Impact factor: 3.850

3.  Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.

Authors:  Ana Paula Caresia; Joan Castell-Conesa; Montserra Negre; Antoni Mestre; Gemma Cuberas; Anabel Mañes; Xavier Maldonado
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

4.  Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.

Authors:  V Vallejos; C Balaña; M Fraile; Y Roussos; J Capellades; P Cuadras; R Ballester; A Ley; A Arellano; R Rosell
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

5.  Voxel-based analysis of (201)Tl SPECT for grading and diagnostic accuracy of gliomas: comparison with ROI analysis.

Authors:  Tomoyuki Kuwako; Sunao Mizumura; Ryusuke Murakami; Tamiko Yoshida; Masato Shiiba; Hidetaka Sato; Yoshimitsu Fukushima; Akira Teramoto; Shin-Ichiro Kumita
Journal:  Ann Nucl Med       Date:  2013-04-17       Impact factor: 2.668

6.  Exophytic cerebellar glioblastoma in the cerebellopontine angle: case report and review of the literature.

Authors:  Masahide Matsuda; Kuniyuki Onuma; Kaishi Satomi; Kei Nakai; Tetsuya Yamamoto; Akira Matsumura
Journal:  J Neurol Surg Rep       Date:  2014-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.